Close

Product Liability Lawyer Blog

Updated:

A Look at Atrial Fibrillation Treatment Options, Including Pradaxa

Atrial Fibrillation (Afib) is a serious medical condition that affects about one in ten Americans over the age of 65.  If someone suffers from atrial fibrillation, which is defined as an irregular heartbeat not associated with a heart valve defect, they will experience what doctors call “bouts” of the condition.…

Updated:

Report: New Applications for Anticoagulant Medications – At What Risk?

A recent article from Medpage Today looks at new uses being proposed for a class of medications know as new oral anticoagulants (NOACs).  This is a fairly new class of medications that includes Xarelto, Eliquis, Pradaxa, and Savaysa.  These medications were designed primary to treat patients who suffer from a…

Updated:

Study: Testosterone Replacement Therapy May Benefit Diabetic Men

Over the past decade, testosterone replacement therapy (TRT) has become a one of the most prescribed medications available, with hundreds of thousands undergoing the therapy each year. However, it should be noted that the vast majority of these patients are not taking the drug because they have the medical condition…

Updated:

Report: Persons with Mental Health Issues Suffer More Complications after Hip Replacement Surgery

In a recent news feature from Tech Times, a study was discussed which suggests that patients with mental health issues tend to have more complications following total hip replacement surgery than those who do not suffer from mental illness. This study also suggests that doctors who are going to perform…

Updated:

New Complications with Total Knee Replacement Surgery

In the United States, a total knee replacement operation is among the most commonly performed types of elective surgery, with hundreds of thousands of procedures being done each year.  There is also a trend for younger patients to undergo total knee replacement procedures. In the past, it was mostly an…

Updated:

Xarelto Makers Claim Their Drug is Superior to Warfarin in “Real World Analysis”

Janssen, which is a division of pharmaceutical giant Johnson & Johnson, is the U.S. marketing partner of Bayer, the German drugmaker that manufactures Xarelto, and has released a report that its new oral anticoagulant (NOAC) is superior to Warfarin (Coumadin) in reducing the risk of ischemic stroke, according to a…

Contact Us